FCI
BPMC

Financial Counselors Inc’s Blueprint Medicines BPMC Stock Holding History

Financial Counselors Inc’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,020
Closed -$216K – 517
2021
Q4 		$216K Buy
2,020
+10
+0.5% +$1.05K ﹤0.01% 487
2021
Q3 		$207K Buy
+2,010
New +$187K ﹤0.01% 515
2021
Q2 		– Sell
-2,300
Closed -$224K – 534
2021
Q1 		$224K Sell
2,300
-420
-15% -$41.9K 0.01% 499
2020
Q4 		$305K Sell
2,720
-210
-7% -$22.1K 0.01% 427
2020
Q3 		$272K Buy
2,930
+90
+3% +$6.93K 0.01% 419
2020
Q2 		$222K Sell
2,840
-1,690
-37% -$114K 0.01% 462
2020
Q1 		$265K Buy
4,530
+980
+28% +$63.1K 0.01% 380
2019
Q4 		$284K Buy
3,550
+30
+0.9% +$2.25K 0.01% 438
2019
Q3 		$259K Buy
3,520
+470
+15% +$40.6K 0.01% 442
2019
Q2 		$288K Buy
3,050
+170
+6% +$14K 0.01% 410
2019
Q1 		$231K Buy
+2,880
New +$213K 0.01% 457

Other funds holding BPMC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Financial Counselors Inc's BPMC Position: Q1 2022 in Review

Financial Counselors Inc sold out of Blueprint Medicines (BPMC) in Q1 2022, closing a stake of 2,020 shares — an estimated $216K sold.

Financial Counselors Inc first reported a position in BPMC in Q1 2019 and held it in 11 quarters. The position peaked at $305K in Q4 2020. 248 funds tracked by Wall St. Rank hold BPMC as of Q1 2022.

  • Financial Counselors Inc reported no remaining Blueprint Medicines position as of Q1 2022 after selling out during the quarter.
  • Financial Counselors Inc sold 2,020 Blueprint Medicines shares in Q1 2022, an estimated $216K.
  • Financial Counselors Inc first reported a position in Blueprint Medicines in Q1 2019 and held it in 11 quarters.
  • Financial Counselors Inc's Blueprint Medicines position peaked at $305K in Q4 2020.
  • 248 funds tracked by Wall St. Rank held Blueprint Medicines as of Q1 2022.

Based on Financial Counselors Inc's 13F filing for Q1 2022, filed 28 Apr 2022.